# Liraglutide and Peripheral Artery Disease

> **NCT04881110** · PHASE4 · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 60 (actual)

## Conditions studied

- Type 2 Diabetes
- Peripheral Arterial Disease

## Interventions

- **DRUG:** Liraglutide
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT04881110
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881110, "Liraglutide and Peripheral Artery Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04881110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*